Workshop– significant benefit of orphan drugs: concepts and future developments
Event
Date
- Thursday, 12 January 2012, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
The aim of the workshop was to discuss the concept of significant benefit and its assessment from orphan designation to marketing authorisation and through protocol assistance. Participants were members of EMA scientific committees and EMA staff. Registration by invitation only.